MAPK8 and acute lymphoblastic leukemia: To verify that the inhibitory effects of SP600125 on T-ALL cells are due to the specific inhibition of JNK signaling, Jurkat cells were transduced with DN-AP1 to repress JNK signaling by antagonizing AP1-mediated transcription downstream of JNK.